Association between mitochondrial DNA copy number and cardiovascular disease: Current evidence based on a systematic review and meta-analysis
PLoS ONE2018Vol. 13(11), pp. e0206003–e0206003
Citations Over TimeTop 10% of 2018 papers
Yue Peng, Siyuan Jing, Lei Liu, Fan Ma, Yi Zhang, Chuan Wang, Hongyu Duan, Kaiyu Zhou, Yimin Hua, Gang Wu, Yifei Li
Abstract
Although inter-study variability, the overall performance test of mtDNA for evaluating CVD and SCD revealed that the mtDNA copy number presented the potential to be a biomarker for CVD and SCD prediction. Given that, the fewer copies of mtDNA, the higher the risk of CVD.
Related Papers
- → Systematic reviews are rarely used to contextualise new results—a systematic review and meta-analysis of meta-research studies(2022)19 cited
- → Measurement of ATP production in mitochondrial disorders(2006)37 cited
- → Large Mitochondrial DNA Deletion in an Infant with Addison Disease(2011)13 cited
- → Comprehensive Molecular Diagnosis of Mitochondrial Disorders: Qualitative and Quantitative Approach(2004)20 cited
- → Genome editing to treat mitochondrial DNA disorders(2015)